A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
Clinical trial NCT07215975 · RECRUITING
Trial details
- NCT number
- NCT07215975
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-25
- Primary completion
- 2030-02-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.